Clinical and moral challenges of pharmacogenomics.

doi:10.5840/ncbq2001147

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinical and moral challenges of pharmacogenomics.

The national Catholic bioethics quarterly - 1 Jan 2001

Issa A M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Family Relations
Share to Genetic Research
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetics, Medical

Share to Health Services Accessibility

Share to Pharmacogenetics

Share to Prejudice

Source

Open in PubMed

Identifiers

PMID: 12854555
DOI: 10.5840/ncbq2001147

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and moral challenges of pharmacogenomics.PMID 12854555Read ↗

Ethical, social and legal issues in pharmacogenomicsSemantic proximity Read ↗

Pharmacogenomics and diagnostics.Semantic proximity Read ↗

Pharmacogenomics: time to rethink its role in precision medicine.Semantic proximity Read ↗

Ethical considerations in clinical pharmacogenomics researchSemantic proximity Read ↗

Pharmacogenomics in drug development: societal and technical aspects.Semantic proximity Read ↗

Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs.Semantic proximity Read ↗

Emerging strategies and applications of pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomics and personalized medicine: mapping of future value creation.Semantic proximity Read ↗

Pharmacogenomics: playing the odds.Semantic proximity Read ↗

Why pharmacogenomics? Why now?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.